1. Home
  2. CVAC vs NTGR Comparison

CVAC vs NTGR Comparison

Compare CVAC & NTGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • NTGR
  • Stock Information
  • Founded
  • CVAC 2000
  • NTGR 1996
  • Country
  • CVAC Germany
  • NTGR United States
  • Employees
  • CVAC N/A
  • NTGR N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • NTGR Telecommunications Equipment
  • Sector
  • CVAC Health Care
  • NTGR Utilities
  • Exchange
  • CVAC Nasdaq
  • NTGR Nasdaq
  • Market Cap
  • CVAC 764.4M
  • NTGR 638.3M
  • IPO Year
  • CVAC 2020
  • NTGR N/A
  • Fundamental
  • Price
  • CVAC $4.47
  • NTGR $29.33
  • Analyst Decision
  • CVAC Strong Buy
  • NTGR Buy
  • Analyst Count
  • CVAC 2
  • NTGR 1
  • Target Price
  • CVAC $14.00
  • NTGR $29.00
  • AVG Volume (30 Days)
  • CVAC 779.9K
  • NTGR 511.5K
  • Earning Date
  • CVAC 05-20-2025
  • NTGR 04-30-2025
  • Dividend Yield
  • CVAC N/A
  • NTGR N/A
  • EPS Growth
  • CVAC N/A
  • NTGR N/A
  • EPS
  • CVAC 0.87
  • NTGR 0.85
  • Revenue
  • CVAC $566,039,775.00
  • NTGR $671,233,000.00
  • Revenue This Year
  • CVAC N/A
  • NTGR $4.48
  • Revenue Next Year
  • CVAC $37.79
  • NTGR $5.04
  • P/E Ratio
  • CVAC $5.16
  • NTGR $34.69
  • Revenue Growth
  • CVAC 787.60
  • NTGR N/A
  • 52 Week Low
  • CVAC $2.37
  • NTGR $13.22
  • 52 Week High
  • CVAC $5.28
  • NTGR $31.55
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 65.61
  • NTGR 56.36
  • Support Level
  • CVAC $3.35
  • NTGR $28.73
  • Resistance Level
  • CVAC $4.80
  • NTGR $31.15
  • Average True Range (ATR)
  • CVAC 0.30
  • NTGR 1.02
  • MACD
  • CVAC 0.07
  • NTGR -0.22
  • Stochastic Oscillator
  • CVAC 77.51
  • NTGR 26.62

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About NTGR NETGEAR Inc.

Netgear Inc is a provider of networking solutions. The reportable segments of the company are connected home, and Small and Medium Businesses (SMB). The Connected Home segment focuses on consumers and consists of high-performance, dependable, and easy-to-use 4G/5G mobile, Wi-Fi internet networking solutions, and smart devices such as Orbi Voice smart speakers and Meural digital canvas; and NETGEAR specializes in providing networking solutions for businesses, including wireless LAN, Pro AV applications for audio and video over Ethernet, security, and remote management.

Share on Social Networks: